• DO YOU WANT TO KNOW CELLIX
    INNOVATION
    Check Cellix R&D Pipeline and Features
  • 46 U.S PATENTS ISSUED , 14 U.S PATENTS PENDING
  • AND REPURPOSING DRUGS
  • FOR BETTER CLINICAL OUTCOMES

Cellix Bio

Cellix Bio is an early stage pharmaceutical company engaged in the development of targeted therapies and proprietary prodrugs that improve one or more of the attributes of approved drugs, such as efficacy, therapeutic index, bioavailability and safety.The alignment of priorities on the franchises and the implementation of project teams – which bring together a broad range of competencies focused on shared objectives – are the pillars of Cellix Bio’s collaborative innovation model.

Cellix intent is to develop targeted therapies and proprietary prodrugs that have improved properties over approved drugs and address unmet medical needs in large, established markets and emerging markets (CIS, Asia, Africa, Latin America etc.) and India.